Neurogene Inc. NGNE
| Analyste |
Entreprise |
Prix lors de l'analyse |
Prix cible |
Gain potentiel |
Date de publication |
| Keith Tapper |
BMO Capital |
10.89 $ |
16 $ |
5.11 % |
14/04/2025 |
| Joel Beatty |
Robert W. Baird |
14.2 $ |
38 $ |
23.80 % |
25/03/2025 |
| Mitchell Kapoor |
H.C. Wainwright |
14.2 $ |
50 $ |
35.80 % |
25/03/2025 |
| Paul Matteis |
Stifel Nicolaus |
15.33 $ |
46 $ |
30.67 % |
20/11/2024 |
| Keith Tapper |
BMO Capital |
35.59 $ |
45 $ |
9.41 % |
19/11/2024 |
| Keith Tapper |
BMO Capital |
64.48 $ |
60 $ |
-4.48 % |
12/11/2024 |
| Paul Matteis |
Stifel Nicolaus |
64.48 $ |
60 $ |
-4.48 % |
12/11/2024 |
| Mitchell Kapoor |
H.C. Wainwright |
35.59 $ |
49 $ |
13.41 % |
12/08/2024 |
| Keith Tapper |
BMO Capital |
32.01 $ |
65 $ |
32.99 % |
26/06/2024 |
| Joel Beatty |
Robert W. Baird |
37.35 $ |
54 $ |
16.65 % |
10/06/2024 |
| Mitchel Kapoor |
H.C. Wainwright |
30.26 $ |
51 $ |
20.74 % |
13/05/2024 |